Literature DB >> 11984567

Angiogenesis inhibitors revised and revived at AACR. American Association for Cancer Research.

Kristine Novak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11984567     DOI： 10.1038/nm0502-427

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

1.  Local delivery of a synthetic endostatin fragment for the treatment of experimental gliomas.

Authors:  Gustavo Pradilla; Federico G Legnani; Giovanna Petrangolini; Pierangelo Francescato; Francesco Chillemi; Betty M Tyler; Sergio M Gaini; Henry Brem; Alessandro Olivi; Francesco DiMeco
Journal:  Neurosurgery       Date:  2005-11       Impact factor: 4.654

2.  Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis.

Authors:  Kathleen M Schmainda; Scott D Rand; Allen M Joseph; Rebecca Lund; B Doug Ward; Arvind P Pathak; John L Ulmer; Michael A Badruddoja; Michael A Baddrudoja; Hendrikus G J Krouwer
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

3.  Simulation of tumor-induced angiogenesis and its response to anti-angiogenic drug treatment: mode of drug delivery and clearance rate dependencies.

Authors:  Daniel Tee; Joseph DiStefano
Journal:  J Cancer Res Clin Oncol       Date:  2003-10-28       Impact factor: 4.553

Review 4.  Use of ribosome-inactivating proteins from Sambucus for the construction of immunotoxins and conjugates for cancer therapy.

Authors:  José M Ferreras; Lucía Citores; Rosario Iglesias; Pilar Jiménez; Tomás Girbés
Journal:  Toxins (Basel)       Date:  2011-04-29       Impact factor: 4.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.